Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 23.64 CHF -0.08% Market Closed
Market Cap: 888.2m CHF
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+142%
Revenue
Forecast
+220%
Operating Income
Forecast
+23%
Net Income
Forecast
+47%

Wall Street
Price Targets

KURN Price Targets Summary
Kuros Biosciences AG

Wall Street analysts forecast KURN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KURN is 32.39 CHF with a low forecast of 31.31 CHF and a high forecast of 34.13 CHF.

KURN Lowest Forecast
Wall Street Target
31.31 CHF
32% Upside
KURN Average Forecast
Wall Street Target
32.39 CHF
37% Upside
KURN Highest Forecast
Wall Street Target
34.13 CHF
44% Upside
Lowest
Price Target
31.31 CHF
32% Upside
Average
Price Target
32.39 CHF
37% Upside
Highest
Price Target
34.13 CHF
44% Upside
Kuros Biosciences AG Competitors:
Price Targets
4
4BB
4Basebio PLC
106% Upside
TH
Theratechnologies Inc
24% Upside
HALO
Halozyme Therapeutics Inc
5% Downside
VCEL
Vericel Corp
69% Upside
4
4BB
4Basebio PLC
106% Upside
TH
Theratechnologies Inc
24% Upside
HALO
Halozyme Therapeutics Inc
5% Downside
VCEL
Vericel Corp
69% Upside
LXRX
Lexicon Pharmaceuticals Inc
149% Upside
FHTX
Foghorn Therapeutics Inc.
125% Upside

Revenue
Forecast

Revenue Estimate
Kuros Biosciences AG

For the last 8 years the compound annual growth rate for Kuros Biosciences AG's revenue is 75%. The projected CAGR for the next 3 years is 32%.

75%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Kuros Biosciences AG

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 3 years is 478%.

N/A
Past Growth
478%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Kuros Biosciences AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
KURN intrinsic value, competitors valuation, and company profile.
DCF Valuation
KURN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KURN stock valuation using valuation multiples.
Wall Street Estimates
KURN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KURN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KURN's stock price target?
Price Target
32.39 CHF

According to Wall Street analysts, the average 1-year price target for KURN is 32.39 CHF with a low forecast of 31.31 CHF and a high forecast of 34.13 CHF.

What is Kuros Biosciences AG's Revenue forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for Kuros Biosciences AG's revenue is 75%. The projected CAGR for the next 3 years is 32%.

What is Kuros Biosciences AG's Operating Income forecast?
Projected CAGR
478%

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 3 years is 478%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 281,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.